↓ Skip to main content

FAM167A is a key molecule to induce BCR-ABL-independent TKI resistance in CML via noncanonical NF-κB signaling activation

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, March 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
9 Mendeley